about
Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 traffickingQuantitative analysis of protein and gene expression in salivary glands of Sjogren's-like disease NOD mice treated by bone marrow soupA case report of Sjögren syndrome manifesting bilateral basal ganglia lesions.Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like diseaseIL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transferInnate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse modelMouse Models of Primary Sjogren's Syndrome.Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndromeBeyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's SyndromeMuscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.Systems analysis of salivary gland development and disease.Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditionsSjögren syndrome: advances in the pathogenesis from animal models.Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic miceT Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeAnimal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in miceA rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.Exocrine Gland Morphogenesis: Insights into the Role of Amphiregulin from Development to Disease.Human T-Lymphotrophic Virus Type-I: A Unique Association with Myelopathy in Sjögren's SyndromeReduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.Decreased submandibular adiponectin is involved in the progression of autoimmune sialoadenitis in non-obese diabetic mice.
P2860
Q27323059-559E8B9F-01D3-4123-BD13-5EFE417B4C35Q28539302-43D7FAC7-7357-4D02-994C-14A10C2B9637Q33627160-42CDE0C0-AFA6-40F5-83D0-7B3C160F1798Q34299698-D75D6BE3-2C6A-43C5-B9BD-79DB1BAE717CQ34448523-1D14E719-A1E1-4283-94CD-001D1537495BQ34614045-7D55CB5E-1D89-4655-87FF-1DCAD0DF7F3CQ35023259-D2F52B8C-23DD-414F-AEC5-FF3E7CDE24DAQ35587450-80C5A147-DB84-4266-AFBF-F716CA9F10CCQ35676007-CE3129EA-3379-4430-87B0-2B9AB56D9C5AQ35911677-079DD464-2BA2-4EC0-83BA-603F1240C431Q36057390-249CD24C-8DBA-44AF-B522-2293927E33A2Q36099617-3A3ACB06-D81C-4C21-906F-04E2D2A851C8Q36161896-16E15906-544D-4576-9BF3-28F90F1B4F44Q36226075-2781E6EF-38D2-46B0-BA63-27D4EF6A6133Q36633351-3254D4C9-4C4A-4277-851F-B79B5C444031Q36925952-71D1E4C5-C584-4689-AEC7-505BD0A003F2Q36957148-B91C1B58-26B9-46EE-A61B-144007A9DC21Q37016308-AF2F7833-4B74-4AF7-ABC8-46EE0F9605A3Q37060371-A56686DC-61CE-450D-BC02-F358428265C0Q37228071-0FF2BABE-EDED-4D20-9715-7B131AA81C26Q37497899-3854CCE9-DDF4-45B2-AA1C-893881BBD660Q37501812-0DA8B41C-F095-4C31-AB77-BC2F1C5E40BBQ37733323-3A0AF48A-76FD-4DA5-8572-FA6CC122D8FDQ39358786-1567C5F0-68AC-4C9A-B9A2-83E7F191C5DDQ39935470-B4A45200-61C5-4F4C-977B-F4A7E38CFB38Q47230722-2B2E7FD7-B7F9-4486-B80E-A0799A9F292DQ52572230-811F5BC1-8DB4-431A-B629-8BDD9D479A74Q54352730-7EBA9B2F-8A38-451E-B374-7B549534AEFBQ54402434-84DAE149-A2F5-4346-8DB5-8F3774DAB55F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sjögren's syndrome: an old tale with a new twist
@en
Sjögren's syndrome: an old tale with a new twist.
@nl
type
label
Sjögren's syndrome: an old tale with a new twist
@en
Sjögren's syndrome: an old tale with a new twist.
@nl
prefLabel
Sjögren's syndrome: an old tale with a new twist
@en
Sjögren's syndrome: an old tale with a new twist.
@nl
P2093
P2860
P1476
Sjögren's syndrome: an old tale with a new twist
@en
P2093
Byung Ha Lee
Cuong Q Nguyen
Mauro A Tudares
P2860
P2888
P356
10.1007/S00005-009-0002-4
P577
2009-01-01T00:00:00Z